+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 65Years
All Genders
ID05062005

Comparing Chemoradiotherapy Alone to Induction Chemotherapy Plus Chemoradiotherapy in Adults With Locally Advanced Nasopharyngeal Carcinoma Phase 3 Clinical Trial

Led by First Affiliated Hospital, Sun Yat-Sen University · Updated on 2021-09-30

447

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating treatment options for patients with locally advanced nasopharyngeal carcinoma. This phase III trial compares two approaches concurrent chemoradiotherapy alone versus induction chemotherapy followed by concurrent chemoradiotherapy. The goal is to determine if the combined approach is not worse than concurrent chemoradiotherapy by itself for this condition. The study is sponsored by the First Affiliated Hospital, Sun Yat-Sen University. Participants are assigned randomly to one of two groups. One group receives induction chemotherapy using regimens such as TP, TPF, or GP administered every three weeks, followed by concurrent chemotherapy with cisplatin every three weeks alongside radiotherapy. Radiotherapy is given once daily, five times per week, with a total dose of 66 to 70 Gy. The other group receives concurrent chemoradiotherapy without induction chemotherapy. During the study, participants are monitored for three years to assess failure-free survival as the primary outcome. Secondary outcomes include overall survival, locoregional recurrence-free survival, distant metastasis-free survival, and adverse events. Researchers evaluate participants health regularly through clinical assessments during this period to understand how each treatment approach affects these outcomes.

CONDITIONS

Brief Title

ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma

Research Team

S

Shuang Wu, PHD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here